The effect of circulating zinc, selenium, copper and vitamin K 1 on COVID-19 outcomes: a Mendelian randomization study

This article has 1 evaluations Published on
Read the full article Related papers
This article on Sciety

Abstract

Background

Previous results from observational, interventional studies and in vitro experiments suggest that certain micronutrients have anti-viral and immunomodulatory activities. In particular, it has been hypothesized that zinc, selenium, copper and vitamin K 1 have strong potential for prophylaxis and treatment of COVID-19.

Objectives

We aimed to test whether genetically predicted Zn, Se, Cu or vitamin K 1 levels have a causal effect on COVID-19 related outcomes: risk of infection, hospitalization and critical illness.

Methods

We employed two-sample Mendelian Randomization (MR) analysis. Our genetic variants derived from European-ancestry GWAS reflected circulating levels of Zn, Cu, Se in red blood cells as well as Se and vitamin K 1 in serum/plasma. For the COVID-19 outcome GWAS, we used infection, hospitalization or critical illness. Our inverse-variance weighted (IVW) MR analysis was complemented by sensitivity analyses: more liberal selection of variants at genome-wide subsignificant threshold, MR-Egger and weighted median/mode tests.

Results

Circulating micronutrient levels show limited evidence of association with COVID-19 infection with odds ratio [OR] ranging from 0.97 (95% CI: 0.87-1.08, p -value=0.55) for zinc to 1.07 (95% CI: 1.00-1.14, p -value=0.06) – ie. no beneficial effect for copper, per 1 SD increase in exposure. Similarly minimal evidence was obtained for the hospitalization and critical illness outcomes with OR from 0.98 (95% CI: 0.87-1.09, p -value=0.66) for vitamin K1 to 1.07 (95% CI: 0.88-1.29, p -value=0.49) for copper, and from 0.93 (95% CI: 0.72-1.19, p -value=0.55) for vitamin K 1 to 1.21 (95% CI: 0.79-1.86, p -value=0.39) for zinc, respectively.

Conclusions

This study does not provide evidence that supplementation with zinc, selenium, copper or vitamin K 1 can prevent SARS-CoV-2 infection, critical illness or hospitalization for COVID-19.

Related articles

Related articles are currently not available for this article.